Table 1.
Immunoconjugates and targeted therapies for HCL
View large
Immunoconjugates and targeted therapies for HCL

rIT indicates recombinant immunotoxin; TKI, thymidine kinase inhibitor; and NHL, non-Hodgkin lymphoma.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal